Month: December 2024

Safetica Launches Intelligent Data Security To Protect Enterprise Teams As They Work

New Safetica release introduces AI-powered technology to accurately evaluate data risks and secure sensitive enterprise data

Today Safetica, the leader in Data Security solutions, announced the launch of Intelligent Data Security, a groundbreaking new way for enterprises to protect their sensitive data.

Intelligent Data Security protects enterprise data using an advanced AI-powered technology called Contextual Defense. In modern dynamic work environments, traditional security tools often fall short because they lack the ability to comprehend the intricate context surrounding each individual data operation. Intelligent Data Security looks beyond the content at the who, what, when, where and how of operations involving sensitive data, to understand where the real data risks are. This thorough analysis allows it to gain a profound understanding of where the genuine data risks lie, enabling organizations to address potential vulnerabilities with greater precision and effectiveness. By considering these multifaceted aspects, Intelligent Data Security ensures that enterprises are not only aware of the content but also the broader context, which is crucial for identifying and mitigating real threats to their valuable data assets.

“Traditional Data Loss Prevention (DLP) tools are complex, and time-consuming to deploy. We’re pushing the boundaries of what is possible. I believe that Safetica is setting a new standard in the industry, making data protection easier, more understandable and accessible – and creating a safer environment.”

Mirek Kren, CEO of Safetica

The technology announced today combines a rich mix of contextual signals including metadata, applications, and user behavior to accurately classify sensitive data, precisely identify risky behavior, and then adapt defenses to implement proactive security measures exactly where they are needed.

Intelligent Data Security comes with built-in intelligence and smart, ready to use policies that provide protection from the moment Safetica is deployed, which is typically in less than an hour. This rapid deployment capability ensures that organizations can quickly enhance their data protection strategies without significant downtime or disruption to their operations.

“This marks an important step forward for Safetica, reflecting our commitment to innovation and our efforts to broaden our impact in the field of data security”.

Mirek Kren, CEO of Safetica

More information about Safetica Intelligent Data Security can be found here.

Media Contact
Company Name: Safetica
Contact Person: Mirek Kren
Email: Send Email
Phone: +1 408 668 1241
Country: United States
Website: http://www.safetica.com

Cardinal Point Wealth Management Alerts Canadians on Understanding the Tax Implications of Leaving Canada

Moving from Canada to another country is a complex process that requires more than just logistical arrangements. Cardinal Point Wealth Management is drawing attention to the essential tax considerations Canadians must be aware of when planning to emigrate, ensuring individuals and families fully understand and comply with Canadian tax laws. Whether the move is prompted by work, retirement, or personal reasons, comprehensive tax planning is necessary to avoid costly surprises and maintain financial well-being.

Tax Residency: A Crucial Determinant

Understanding tax residency status is a vital step in managing tax obligations when leaving Canada. Cardinal Point emphasizes that tax residency determines whether Canadian tax laws apply to an individual’s worldwide income. Significant ties to Canada, such as a primary residence, family, or economic interests, generally result in maintaining tax residency.

When a person severs these residential ties, they may cease to be a Canadian tax resident. This status change often coincides with the latest of the following dates: the day the individual departs from Canada, the date their spouse or dependents leave, or when they establish residency in their new country. For individuals facing uncertainty about their residency status, Form NR73 can be used to seek a formal determination from the Canada Revenue Agency, although it is not mandatory to submit.

Taxation of Income Upon Departure

In the year of departure, Canadians are taxed as residents on their worldwide income up to the date they cease to be residents. Afterward, they will be considered non-residents, only taxed on income derived from Canadian sources. Cardinal Point highlights that understanding this distinction is crucial for proper income reporting.

Deemed Disposition and Departure Tax

A key aspect of Canadian tax law for emigrants is the departure tax, which applies to certain assets that are considered “deemed disposed” at fair market value on the date of departure. This measure ensures that Canada taxes the appreciation of these assets during the individual’s residency. Fifty percent of any net gains are included as income and taxed at regular marginal rates. Cardinal Point underscores the importance of evaluating asset portfolios and understanding which assets are subject to this tax.

Investments and Pensions

Investment and pension assets present specific challenges and opportunities. For example, non-registered investment accounts are subject to deemed disposition rules, and investment income earned post-departure is subject to withholding tax. Those moving to the United States may file for a basis adjustment under the Canada-U.S. Tax Convention and should consider transferring accounts to a U.S. custodian. Cardinal Point, uniquely registered in both Canada and the United States, can manage these accounts seamlessly.

Canadian employee stock options are not subject to deemed disposition upon emigration, but any benefits from exercising options will be taxable in Canada. The implications for shares of a Canadian-Controlled Private Corporation (CCPC), Tax-Free Savings Accounts (TFSAs), Registered Education Savings Plans (RESPs), and Registered Retirement Savings Plans (RRSPs) vary, and planning is crucial to optimize outcomes.

Real Property in Canada

Real estate held in Canada is not subject to deemed disposition. However, Cardinal Point notes that rental income from Canadian properties will incur a 25% non-resident tax on gross income. Proper tax planning can mitigate this, and electing to file Form NR6 allows taxation on net rental income, often resulting in a more favorable tax outcome.

Filing Requirements

Those emigrating from Canada must file a T1 Emigration Income Tax Return, reporting worldwide income up to the departure date. The deadline is April 30 of the following year (June 15 for self-employed individuals). Additional forms, such as T1161 for property disclosures and T1243 for listing properties subject to deemed disposition, are essential to ensure compliance.

For those continuing to earn rental or Canadian Benefits income, Section 216 and Section 217 returns provide options to optimize tax efficiency. Cardinal Point advises that working with a cross-border wealth management expert can help navigate these requirements.

About Cardinal Point Wealth Management

Cardinal Point Wealth Management is a leading provider of cross-border wealth management and cross-border tax planning services. With expertise in managing complex cross-border financial scenarios between Canada and the United States, Cardinal Point is dedicated to providing personalized solutions that ensure compliance and financial efficiency. Their team of experienced professionals is well-versed in the intricacies of cross-border tax planning and tax laws, helping clients seamlessly manage their assets and investments across borders.

Disclaimer: This press release may contain forward-looking statements. Forward-looking statements describe future expectations, plans, results, or strategies (including product offerings, regulatory plans and business plans) and may change without notice. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements.

Media Contact
Company Name: Cardinal Point Wealth Management
Contact Person: Kris Rossignoli
Email: Send Email
Phone: 8662132036
Address:2255 Glades Road, Suite 324A
City: Boca Raton
State: FL 33431
Country: United States
Website: https://cardinalpointwealth.com/

Gary Fowler, CEO of GSD Venture Studios, Leads Global Innovation in AI and Quantum Computing, Empowering Startups and Shaping the Future of Technology

Gary Fowler is leading the revolution in artificial intelligence (AI) and quantum computing by running the innovation race across the entire globe. He has been in this domain for over 30 years. Through his ventures spanning marketing, sales, and technology, Gary has made himself a tech-first entrepreneur, playing a defining role in the sector as a whole. He is the champion of change, with his activities revolving around wellness and the stakes of health, finance, logistics, and consumer service

Gary’s professional journey is based on a strong conviction that technology, when used correctly, can drastically improve our lives. He has been pursuing this vision all along his career because, at each stage, his step has been to discover and nurture high-potential startups worldwide. His activities cover several technologies, such as generative AI, quantum computing, and hyper-personalization, which, according to these technologies, change industries and, thus, how society deals with technology. 

One of Gary’s most important accomplishments was the development of Yva.ai, a machine learning and predictive analytics-based employee engagement platform that provides profound insights into employee satisfaction and team dynamics. The industry soon noticed the groundbreaking approach to remote work and employee retention that the platform offered, resulting in Yva.ai’s acquisition by Visier, a Canadian analytics company. Visier acquiring Yva.ai shows that Gary possessed the power to develop ideas and scale them to such an extent that they were globally successful.

As the head of GSD Venture Studios, Gary has established an innovative platform that allows startups in the AI and quantum computing areas to speed up their growth. GSD Venture Studios is an international incubator that gives entrepreneurs access to the necessary tools, mentorship, and strategic guidance they require to thrive. With Gary’s help, we have established partnerships worldwide that foster the breakthrough of new ideas and provide startups with more opportunities to prosper anywhere in the world.

Gary’s passion for promoting innovation is not limited to his work at GSD Venture Studios. Over the years, he has been instrumental in the success of several technology companies. One is ClickSoftware, which Salesforce acquired after a successful initial public offering on NASDAQ for $1.35 billion. His involvement in the companies Mirantis, Zemplee, and GVA LaunchGurus is another major proof that his capability of steering through the organization’s development and scaling results in them reaching new levels of success.

Gary has responded to the new business environment that has emerged in the last couple of years, especially in the aftermath of the COVID-19 pandemic. Since the promise of technology often keeps the wheels turning in business, he experimented with AI in healthcare, security, and online collaboration, which are the main pain points. During this period, Gary’s initiative and resilience demonstrate his unyielding dedication to using technology to create increased value for individuals and, ultimately, to solve real-life problems.

As a thought leader in the AI and tech industries, Gary is often invited to give speeches at prestigious conferences such as TEDx, Forbes, and South Summit. His technology-based dream for the future still catches the world’s attention, and he has been bestowed with many awards, such as the title of one of the “Top Ten Most Influential AI Executives.”

Gary’s philosophy is simple but deep: genuine innovation is the result not only of a shift in technology but also caused by the transformation of people’s lives, which is long-lasting and meaningful. His family will witness his legacy in AI and quantum computing as he continues to be the torch bearer. At the same time, his name is associated with innovations and impactful actions that are the mainframe for the tech sector.

Media Contact
Company Name: GSD Family Office
Contact Person: Gary A Fowler
Email: Send Email
Country: United States
Website: http://www.gsdvs.com

OWNRSCLB Launches Innovative New FX Platform To Provide Better Rates for Users

The newly launched platform allows better value money transfer for the Dubai real estate market, whether buying or selling real estate in Dubai.

OWNRSCLB is excited to announce the launch of its new foreign currency exchange platform OWNRSCLB FX, designed to deliver better value for real estate owners with preferential exchange rates when compared to the traditional banks. Platform users can transact in 56 major currencies, at competitive exchange rates with the best rates reserved for individuals with large real estate portfolios. 

With Dubai’s real estate market booming, and global investors flocking to the Middle East to invest in new off-plan projects, property developers in Dubai are witnessing customers seeking to pay in a wide array of currencies; when currencies are converted by the banks customers can routinely lose 3% in foreign exchange fees. 

Furthermore, investors are often concerned about the impact of fluctuating exchange rates, as off-plan projects in Dubai are typically denominated in UAE Dirhams (the currency is pegged to the US dollar), leaving the investor to manage the risk that their local currency devalues against the UAE Dirham. With OWNRSCLUB FX, Investors and prospective homeowners can now remove currency risk by entering into forward contracts fixing their foreign exchange rates for the duration of Off-Plan payment plans, providing a level of certainty over the cost of their investments.

“Launching this platform marks a significant step in our commitment to delivering more value for OWNRSCLB members – it is just the start of what we call a more rewarding way to own Dubai real estate,” said Charles Mpi, CEO. The OWNRSCLB FX perks are not solely reserved for homeowners; other Dubai residents can register within the Bronze tier and enjoy discounted foreign exchange rates when sending money home, and Corporate Clients can also utilise the OWNRSCLB FX platform for currency exchange when paying overseas suppliers or receiving foreign currency receipts from customers. The best rates are reserved for exclusive Diamond tier clients, who have a Dubai real estate portfolio greater than AED 10 million.

The app is part of OWNRSCLB’s broader rewards ecosystem, aimed at rewarding Dubai homeowners, with tiered benefits being granted based on the size of their respective portfolios. OWNRSCLB will feature a range of lifestyle discounts and exclusive experiences, disrupting the Dubai real estate market by enabling direct negotiation between buyers and sellers.

Media Contact
Company Name: OWNRSCLB FX
Contact Person: Melissa Charalambous
Email: Send Email
Country: United Arab Emirates
Website: https://ownersclubfx.com

Clip-Lok SimPak Introduced Custom Steel-Enhanced Packaging for Heavy-Duty Logistics

Clip-Lok SimPak has introduced a custom-engineered packaging solution for Germany’s engine manufacturing sector, designed to transport 1,000 kg of heavy metal engine parts. The innovative system combines robust steel pallets with reusable wooden panels, offering modular construction, space-saving flat-packing, and durability for over 100 uses. Replacing less reliable chip block packaging, this solution enhances operational efficiency, reduces costs, and aligns with sustainability goals, solidifying Clip-Lok SimPak’s position as a leader in industrial packaging.

Leading industrial packaging innovator, Clip-Lok SimPak, has introduced a custom-engineered packaging solution for heavy truck and engine parts distribution within Germany’s engine manufacturing sector. Responding to an engine plant’s need for a reusable packaging system capable of transporting 1,000 kg of heavy metal engine components, Clip-Lok SimPak has developed a robust, steel-enhanced solution that meets both durability and sustainability standards.

The Challenge: Inadequate Strength in Standard Packaging Solutions

Previously, the plant utilized chip block construction packaging with 18mm plywood runners, however forklift damage to pallets led to increased maintenance, potential downtime, and safety concerns. Therefore the car manufacturer to transport heavy metal parts was looking for a more durable solution. With this in mind, Clip-Lok SimPak engineered a packaging solution that not only meets the payload requirements but also ensures a secure and repeatable solution for heavy-duty logistics.

Clip-Lok’s Innovative Steel and Wood Solution

Clip-Lok SimPak’s new design incorporates a robust steel pallet with the brand’s signature reusable wooden panels. The packaging system retains Clip-Lok’s traditional advantages:

–  Modular Construction: Panels are secured individually, allowing for side, end, or top access for loading and unloading. Damaged parts can be easily replaced without replacing the entire unit.

–  Space-Saving and Cost-Efficient: When empty, the system can be flat-packed, providing up to 80% reduction in return transport costs and warehouse storage requirements.

–  Sustainability: Built to withstand repeated use, the Clip-Lok solution can typically be reused over 100 times, promoting long-term cost savings and environmental benefits.

Proven Reliability and Performance

Since the adoption of Clip-Lok’s solution, there have been no reported incidents of broken pallets under high-stress conditions, underscoring the strength and effectiveness of the steel and wood combination. The innovative design enables seamless transport of heavy engine components across facilities and from component manufacturers, thereby enhancing operational efficiency in the supply chain.

Clip-Lok SimPak’s custom-designed packaging is optimized to meet the evolving needs of the automotive and industrial sectors, delivering durability, reusability, and significant cost savings. With this new offering, Clip-Lok SimPak continues to strengthen its reputation as a global leader in smart, sustainable packaging solutions.

About Clip-Lok SimPak

Clip-Lok SimPak is a trusted provider of returnable and customized industrial packaging solutions, with a presence across five continents and in 12 countries. By combining innovative engineering with a commitment to sustainability, Clip-Lok SimPak helps clients optimize their supply chains with durable, cost-effective packaging solutions.

Media Contact
Company Name: Clip-Lok SimPak
Contact Person: Anders
Email: Send Email
Phone: +45 48 14 37 78
Country: Denmark
Website: https://clip-lok.com/

Obesity Market Size was around ~USD 2000 Million (US) in 2023, estimated DelveInsight

DelveInsight’s “Obesity Market Insights, Epidemiology and Market Forecast–2034” report delivers an in-depth understanding of obesity, historical and forecasted epidemiology as well as the obesity market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

 

Discover Key Insights into the Obesity Market with DelveInsight’s In-Depth Report @ Obesity Market Size

 

Key Takeaways from the Obesity Market Report

  • In November 2024:- Carmot Therapeutics Inc.- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Once-Weekly CT-388 Administered Subcutaneously for 48 Weeks to Participants Who Are Overweight or Obese with Type 2 Diabetes Mellitus. This is a multi-center, randomized, double-blind, placebo-controlled, parallel group dose-finding study to evaluate the efficacy and safety of CT-388 at low, middle, and high doses in participants who are overweight or obese with Type 2 diabetes mellitus (T2DM).
  • In November 2024:- Eli Lilly and Company- A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Retatrutide Compared to Tirzepatide in Adults Who Have Obesity. The main purpose of this study is to evaluate the efficacy and safety of retatrutide compared to tirzepatide in adults who have obesity. The study will last about 89 weeks.
  • As per DelveInsight’s estimates, the United States accounted for the highest number of total prevalent cases of Obesity among the 7 MM in 2023.
  • DelveInsight’s consultant estimates that adult patients constituted the maximum number of cases of obesity patients seeking help in 2023.
  • According to the findings, treatment rate for children was found to be less than that of adults across countries.
  • Among EU4 and the UK, the highest number of treated cases of obesity in adults was observed in the United Kingdom in 2023, which is followed by Germany.
  • The leading Obesity Companies such as Rhythm Pharmaceuticals, Boehringer Ingelhium, D&D Pharmatech, ProQR Therapeutics, Nano Precision Medical, Bukwang Pharmaceutical, Caliway Biopharmaceutics, Yuhan, Terns Pharmaceuticals, BioRestorative Therapies, SCOHIA PHARMA, Click Therapeutics, Hanmi Pharmaceuticals, Novo Nordisk, Empros Pharma, Carmot Therapeutics, Eli Lilly and Company, and others
  • Promising Obesity Therapies such as IMCIVREE (setmelanotide), ZEPBOUND (tirzepatide), Semaglutide oral, Survodutide (BI 456906), DD03, AX-0601, NPM 139, BK-1701, CBW-520, YH34160, TERN-601, Thermostem, SCO-267, CT-181, HM15136, NNC0480-0389, EMP-16, CT-868, Semaglutide, and others

 

Stay ahead in the Obesity Therapeutics Market with DelveInsight’s Strategic Report @ Obesity Market Outlook

 

Obesity Epidemiology Segmentation in the 7MM

  • Total Prevalence of Obesity
  • Prevalent Cases of Obesity by severity
  • Gender-specific Prevalence of Obesity
  • Diagnosed Cases of Episodic and Chronic Obesity

 

Download the report to understand which factors are driving Obesity epidemiology trends @ Obesity Prevalence

 

Marketed Obesity Drugs

 

  • IMCIVREE (setmelanotide): Rhythm Pharmaceuticals

Imcivree is a melanocortin 4 (MC4) receptor agonist indicated for chronic weight management in adult and pediatric patients 6 years of age and older with obesity. In November 2020, Rhythm Pharmaceuticals announced the US FDA approval of Imcivree as the first-ever therapy for chronic weight management in patients with obesity due to POMC, PCSK1, or LEPR deficiency. Earlier, in May 2017, FDA expanded the Breakthrough Therapy Designation to disorders involving genetic defects upstream of the melanocortin-4 receptor in the leptin-melanocortin pathway.

 

  • ZEPBOUND (tirzepatide): Eli Lilly and Company

Tirzepatide is a once-weekly glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist that integrates the actions of both incretins into a single novel molecule. In November 2023, the US FDA approved Eli Lilly and Company’s ZEPBOUND (tirzepatide) injection, the first obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors. ZEPBOUND is indicated for adults with obesity (with a BMI of 30 kg/m2 or greater), or those who are overweight (with a BMI of 27 kg/m2 or greater) and also have weight-related medical problems such as hypertension, dyslipidemia, Type II diabetes mellitus, obstructive sleep apnea or cardiovascular disease, to lose weight and keep it off.

 

Emerging Obesity Drugs

  • Semaglutide oral: Novo Nordisk

Oral semaglutide is approved as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes in the US, EU and Japan under the trade name, RYBELSUS. It is an oral GLP-1 RA, an analogue of the naturally occurring hormone GLP-1. Currently, the company is developing the candidate for obesity. The candidate is being evaluated in various Phase III trials (OASIS 1, OASIS 2, OASIS 3 and OASIS 4) to assess the safety and efficacy of the drug in subjects with overweight or obesity.

 

  • Survodutide (BI 456906): Boehringer Ingelhium

Survodutide (BI 456906) is a GCGR/GLP1 dual agonist being developed by Boehringer Ingelhium. GLP1 agonism is expected to lower body weight and provide glucose control. Both receptors are critical to controlling metabolic functions. The compound leverages the known effects of the natural gut hormone oxyntomodulin, which has been shown to decrease food intake and increase energy expenditure in humans as well as the established effects of GLP1 agonism on both glucose control and body weight. The dual agonist BI 456906 has potential as a new, once-weekly treatment that may offer therapeutically relevant benefits compared to currently available treatments.

 

Get In-Depth Knowledge on Obesity Market Trends and Forecasts with DelveInsight @ Obesity Treatment Market

 

Scope of the Obesity Market Report

  • Coverage- 7MM
  • Obesity Companies- Rhythm Pharmaceuticals, Boehringer Ingelhium, D&D Pharmatech, ProQR Therapeutics, Nano Precision Medical, Bukwang Pharmaceutical, Caliway Biopharmaceutics, Yuhan, Terns Pharmaceuticals, BioRestorative Therapies, SCOHIA PHARMA, Click Therapeutics, Hanmi Pharmaceuticals, Novo Nordisk, Empros Pharma, Carmot Therapeutics, Eli Lilly and Company, and others
  • Obesity Therapies- IMCIVREE (setmelanotide), ZEPBOUND (tirzepatide), Semaglutide oral, Survodutide (BI 456906), DD03, AX-0601, NPM 139, BK-1701, CBW-520, YH34160, TERN-601, Thermostem, SCO-267, CT-181, HM15136, NNC0480-0389, EMP-16, CT-868, Semaglutide, and others.
  • Obesity Therapeutic Assessment: Obesity Current marketed and Obesity Emerging Therapies
  • Obesity Market Dynamics: Obesity Market drivers and Obesity Market Barriers

 

Unlock Strategic Insights with DelveInsight’s Comprehensive Obesity Market Report @ Obesity Market Drivers and Barriers

 

Table of Contents

1. Key Insights

2. Report Introduction

3. Obesity Market Overview at a Glance

4. Executive Summary

5. Key Events

6. Epidemiology and Market Methodology

7. Disease Background and Overview

8. Epidemiology and Patient Population

9. Japan Epidemiology Scenario

10. Patient Journey

11. Marketed Therapies

12. Emerging Therapies

13. Obesity Market: The 7MM Analysis

14. Obesity Market Access and Reimbursement

15. KOL Views

16. SWOT Analysis

17. Unmet Needs

18. Appendix

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight 

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/case-study/respiratory-domain-conference-coverage

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Obesity Market Size was around ~USD 2000 Million (US) in 2023, estimated DelveInsight

3D Cell Culture Market with Business Strategy, Key Drivers, Opportunities, Top Key Companies Analysis and Forecast

“The 3D cell culture market is consolidated, with a small number of players competing for market shares. Thermo Fisher Scientific. Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza (Switzerland), and Avantor Inc. (US) are some of the leading players in this market.”
Browse 205 market data Tables and 39 Figures spread through 244 Pages and in-depth TOC on “3D Cell Culture Market by Product (Hydrogels, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Tissue Engineering), End User (Pharma, Biotech, Research), Region – Global Forecast to 2028

3D Cell Culture Market in terms of revenue was estimated to be worth $1.3 billion in 2023 and is poised to reach $2.5 billion by 2028, growing at a CAGR of 14.6% from 2023 to 2028 according to a new report by MarketsandMarkets™. Major factors driving the market growth at significant CAGR are increasing adoption of 3D cell culture over, restrictions over animal testing and increased use of 3D cell culture in personalized medicine.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191072847

Scaffold-based 3D cell culture accounted for the largest share of the product segment in the 3D cell culture market in 2022.

Based on product, the 3D cell culture market is segmented into scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic & bioprinted 3D cell cultures. The scaffold-based 3D cell cultures segment accounted for the largest share in 2022. The advantages of scaffolds in 3D cell cultures, such as structural rigidity, the availability of attachment points, and support, have greatly driven the preference for the segment and ensured its large share in the market.

The cancer & stem cell segment research segment accounted for the largest share of the application segment in the 3D cell culture market in 2022.

Based on application, the market is segmented into cancer & stem cell research, drug discovery & toxicology testing, and tissue engineering & regenerative medicine. Cancer & stem cell segment research accounted for the largest market share of the market in 2022. The increasing prevalence of cancer and significant funding initiatives for cancer research from the government and the private sector are major factors driving the growth of this application segment..

Asia Pacific is likely to grow at the highest growth rate during the forecast period.

Based on region, the 3D cell culture market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America dominated the market, followed by Europe. The increasing incidence of cancer and a well-established pharmaceutical & biotechnology industry are key factors supporting the growth of the North American 3D cell culture market. The Asia Pacific market is projected to grow at the highest CAGR of 16.0% during the forecast period. Most companies in the market focus on organic and inorganic growth strategies, such as product launches, expansions, acquisitions, partnerships, agreements, and collaborations, to increase their product offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=191072847

3D Cell Culture Market Dynamics:

Drivers:

  1. High focus on developing alternatives to animal testing
  2. Greater adoption of personalized medicine globally for multiple diseases
  3. Increased government support and funding for 3D cell culture
  4. Increased industry-academia collaboration on 3D cell culture and research

Restraints:

  1. High costs of implementing 3D cell culture technologies
  2. Lack of widely accepted or single standardization in 3D cell culture

Opportunities:

  1. Emergence of microfluidics-based 3D cell culture
  2. High growth opportunities and booming biopharmaceutical sector in emerging economies

Challenges:

  1. Lack of consistency in 3D cell culture products
  2. High dependence on plastic waste disposals and consumables

Key Market Players:

The 3D cell culture market is consolidated, with a small number of players competing for market shares. Thermo Fisher Scientific. Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza (Switzerland), and Avantor Inc. (US) are some of the leading players in this market.

Recent Developments:

  • In October 2022, Corning launched the Elplasia 12K flask featuring a unique microcavity geometry that enables easy spheroid formation, culture, treatment, assessment, and harvest, with approximately 12,000 spheroids of uniform size and shape per flask, generating 125 times more yield than conventional 96-well spheroid plates.
  • In March 2021, Thermo Fisher Scientific launched a plasma-like medium, a cell culture medium that mimics the metabolic profile of human plasma, designed to provide researchers with a realistic view of cell growth within the human body.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=191072847

3D Cell Culture Market Advantages:

  • Physiological relevance: 3D cell culture models better mimic the complex three-dimensional structure and cellular interactions found in living tissues and organs. This physiological relevance allows for more accurate representation of cell behavior, drug responses, and disease progression, leading to improved reliability and predictive power in preclinical studies.
  • Enhanced drug discovery: 3D cell culture models enable more reliable screening of potential drug candidates by providing a more realistic microenvironment. This helps identify compounds with better efficacy and safety profiles, reducing the cost and time associated with failed clinical trials.
  • Disease modeling: 3D cell cultures can be engineered to recapitulate specific disease conditions, offering researchers a powerful tool for studying disease mechanisms, identifying novel therapeutic targets, and evaluating the effectiveness of potential treatments. This contributes to a deeper understanding of diseases and facilitates the development of personalized medicine approaches.
  • Tissue engineering and regenerative medicine: 3D cell culture systems play a crucial role in tissue engineering and regenerative medicine applications. They allow for the creation of complex tissue constructs with controlled architectures, promoting cell differentiation, tissue formation, and organ development. This opens up possibilities for organ transplantation, replacement therapies, and the development of alternative models for toxicology testing.
  • High-throughput screening: 3D cell culture platforms can be adapted for high-throughput screening, enabling the testing of multiple compounds or interventions simultaneously. This accelerates the drug discovery process and facilitates the identification of promising candidates with higher efficiency.
  • Reduced animal testing: By providing a more accurate representation of human biology, 3D cell culture models can help reduce the reliance on animal testing in preclinical research. This aligns with the growing emphasis on ethical and sustainable research practices.

In summary, the 3D cell culture market offers advantages such as enhanced physiological relevance, improved drug discovery, disease modeling capabilities, tissue engineering potential, high-throughput screening, and reduced reliance on animal testing. These advantages make 3D cell culture an invaluable tool for advancing biomedical research and development in the coming years.

3D cell culture Market – Report Highlights:

  • Key conferences, and events 2022-2023, key stakeholders & buying criteria, pipeline analysis and trends/ disruptions impacting customer business are added in the market overview chapter.
  • The new edition of the report provides updated financial information till 2022 (depending on availability) for each listed company in a graphical representation. This would help in the easy analysis of the present status of profiled companies in terms of their financial strength, profitability, key revenue-generating region/country, and business segment focus in terms of the highest revenue-generating segment.
  • Impact of the recession has also been added in the new addition of the report.
  • Recent developments are helpful to understand market trends and growth strategies adopted by players in the market.
  • The hydrogel/ ECM segment is further subsegmented into synthetic and natural hydrogels.
  • Tracking product portfolios of prominent market players helps to analyze the major products in the 3D cell culture market. The new edition of the report provides an updated service portfolio of the companies profiled in the report.
  • Market evaluation framework, market share analysis, and competitive leadership mapping have been added in the competitive landscape chapter of the report.
  • The competitive leadership mapping has been updated considering recent developments in the company evaluation matrix.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/3d-cell-culture-market-191072847.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: 3D Cell Culture Market with Business Strategy, Key Drivers, Opportunities, Top Key Companies Analysis and Forecast

Breckenridge Technologies Launches New Digital Information Portal and Product Catalog Powered by Agilis

Breckenridge Technologies Launches New Digital Information Portal and Product Catalog Powered by Agilis

Breckenridge Technologies Launches New Digital Information Portal
Enhancing Customer Engagement and Expanding Opportunities in the Specialty Chemical Industry

Breckenridge Technologies, a trusted supplier of specialty raw materials and ingredients since 1996, is excited to announce the launch of its new digital information portal and interactive product catalog, developed in collaboration with Agilis, a leader in digital engagement solutions for the chemical industry. This new platform marks a significant milestone for Breckenridge as they enhance customer engagement, discover new opportunities, and promote their specialty chemical products online.

The new product information portal, accessible through the Breckenridge Technologies website, offers a dynamic and user-friendly experience that allows customers to explore the full range of Breckenridge’s portfolio. Breckenridge is moving beyond the limitations of a static product list, enabling users to easily browse through their extensive portfolio, access technical documents, and inquire about products directly through the portal.

“Launching this portal is a significant step in our digital marketing journey,” said JB Harrell, Vice President at Breckenridge Technologies. “We can manage our product information and provide our customers with a streamlined, interactive experience, while enabling us to promptly respond to their requests for samples and technical support. This platform allows us to better serve our existing customers and identify new ones while promoting our specialty chemicals in a way we haven’t been able to do before.”

Jay Bhatia, CEO of Agilis, commented, “We are thrilled to support Breckenridge Technologies in launching their new digital platform. This collaboration showcases the strength of the Agilis platform in seamlessly digitizing product data to enhance customer engagement and drive strategic growth, all under their own brand with full control of customer relationships.”

To explore Breckenridge Technologies’ digital catalog and learn more about their specialty products, visit Breckenridge Technologies’ Customer Portal.

About Agilis:

Agilis is a leading provider of innovative digital customer engagement solutions tailored for the chemical industry. Established by seasoned chemical industry professionals, Agilis empowers global producers and distributors with a state-of-the-art, intuitive, cloud-based platform that facilitates the creation of personalized digital customer engagement channels. Agilis solutions are engineered to enhance competitive advantage, drive growth, improve customer experiences, and boost operational efficiency for suppliers in the industry. Agilis melds deep industry insights with cutting-edge technology expertise to develop robust, scalable solutions that meet the dynamic needs of today’s market.

For additional details, visit www.agiliscommerce.com.

About Breckenridge Technologies, LLC

Founded in 1996, Breckenridge Technologies has built a reputation for providing high-quality specialty raw materials and ingredients to industries such as Food and Beverage, Chemical Compounding, CASE, Energy Cure, Graphic Arts, HI&I, and Personal Care. With decades of hands-on experience, Breckenridge prides itself on delivering unmatched technical knowledge and customer service to support formulating and logistics needs.

For more information, visit http://www.brecktech.com/

Media Contact
Company Name: Breckenridge Technologies, LLC
Contact Person: JB Harrell
Email: Send Email
Country: United States
Website: https://www.brecktech.com

Online Yoga Teacher Training for Self-Motivation during Winter

Winter often challenges people’s motivation. The shorter days, colder temperatures, and lack of sunlight can lead to low energy, inactivity, and even seasonal blues. However, engaging in a structured, enriching activity can transform this season into a period of growth and inspiration. Gyan Yog Breath’s Online Yoga Teacher Training offers an ideal way to stay active, learn something new, and maintain motivation throughout the winter months.

This self-paced, flexible program is designed to fit into any schedule, making it accessible for anyone seeking personal growth, deeper yoga practice, or a new career in teaching yoga. With the ability to complete the training within 1 to 12 months, participants can set their own pace while benefiting from a comprehensive curriculum that trains both the body and mind.

Why Winter Is the Perfect Time for Yoga Teacher Training

Winter is often viewed as a time to slow down, but it can also be a season of transformation. Engaging in a program like yoga teacher training not only provides a sense of purpose but also supports physical and mental well-being. The colder months are ideal for focusing inward, setting goals, and learning new skills, making an online yoga teacher training program an excellent choice.

Many individuals find that having a structured activity during winter helps them stay consistent and motivated. Yoga, in particular, offers a balance of physical activity and mindfulness, helping to combat the challenges of the season.

The Benefits of Gyan Yog Breath’s Online Yoga Teacher Training

Gyan Yog Breath’s Online Yoga Teacher Training is a unique program tailored for modern lifestyles. It offers numerous benefits for anyone looking to make the most of their winter:

  1. Flexibility to Suit Every Schedule : The program is self-paced, allowing participants to complete the training in as little as one month or take up to a year. This flexibility ensures that anyone, from busy professionals to stay-at-home parents, can work toward their certification without feeling overwhelmed.

  2. Holistic Curriculum : This training goes beyond yoga poses. Participants learn about meditation, pranayama (breathing techniques), yoga philosophy, anatomy, and teaching methodologies. The curriculum encourages personal growth while providing practical skills for future yoga teachers.

  3. Access to Expert Instructors : Participants benefit from the expertise of experienced yoga instructors who provide high-quality video lessons, in-depth course materials, and personalized guidance. This ensures a rich and supportive learning experience.

  4. Convenience of Online Learning : The program can be accessed from anywhere, eliminating the need for travel or fixed schedules. This makes it easy to stay consistent, even during the busiest or coldest days of winter.


How Yoga Teacher Training Helps Participants Stay Motivated

One of the greatest challenges of winter is maintaining motivation. The structured nature of yoga teacher training in India provides a clear goal and a sense of accomplishment, helping participants stay focused and energized. Here’s how the program supports motivation:

  • Physical Activity: Regular yoga practice keeps the body moving, improves flexibility, and strengthens muscles. It’s an excellent way to stay active during a season that often discourages outdoor exercise.

  • Mental Clarity: Meditation and mindfulness practices included in the training help participants manage stress, reduce anxiety, and cultivate a positive mindset.

  • Learning New Skills: Studying yoga philosophy, anatomy, and teaching techniques engages the mind and fosters a sense of achievement. This intellectual stimulation can counteract the sluggishness often associated with winter.

  • Community Connection: Gyan Yog Breath’s program connects participants with a global community of like-minded individuals. This sense of connection can be deeply motivating and uplifting.


A Pathway to Personal and Professional Growth

The training isn’t just for those who want to teach yoga. Many participants enroll to deepen their personal practice, improve their understanding of yoga, or simply to invest in their well-being. For those considering a career in yoga instruction, the program offers a comprehensive certification that is internationally recognized, opening doors to new professional opportunities.

How to Begin the Journey with Gyan Yog Breath

Getting started with Gyan Yog Breath’s Online Yoga Teacher Training is simple. Upon enrollment, participants gain instant access to all course materials, including manuals and study guides. The user-friendly platform ensures that even those new to online learning can navigate the program with ease.

Whether someone is an experienced yogi or a complete beginner, the program provides a clear and supportive pathway to success. With the flexibility to study at their own pace, participants can tailor their experience to match their unique goals and schedules.

Winter: a Season of Transformation

Instead of letting winter pass by in stagnation, individuals can use this season to focus on growth, self-care, and new beginnings. Gyan Yog Breath’s Online Yoga Teacher Training provides the tools and guidance needed to turn the winter months into a period of transformation and achievement.

By staying motivated, learning valuable skills, and nurturing both the body and mind, participants can emerge from winter feeling stronger, more confident, and ready to take on new challenges.

Media Contact
Company Name: Gyan Yog Breath
Contact Person: Bipin Kumar
Email: Send Email
Phone: 9410382099
Address:Nirmal B Block, Pashulok, Vishtapit
City: Rishikesh
State: Uttarakhand
Country: India
Website: https://gyanyogbreath.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Online Yoga Teacher Training for Self-Motivation during Winter

Neuropathic Ocular Pain Market Size is expected to increase with a significant CAGR of 5.2% contributing to projected launch of emerging therapies by 2034, estimates DelveInsight

DelveInsight’s “Neuropathic Ocular Pain Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the NOP, historical and forecasted epidemiology as well as the NOP market trends in the United States, EU4 and the UK (Germany, France, Italy, Spain), the United Kingdom, and Japan.

 

Discover Key Insights into the Neuropathic Ocular Pain Market with DelveInsight’s In-Depth Report @ Neuropathic Ocular Pain Market Size

 

Key Takeaways from the Neuropathic Ocular Pain Market Report

  • In 2023, the total number of Neuropathic Ocular Pain (NOP) cases across various eye disorders and surgeries was estimated to be around 3,075 thousand in the 7MM, with expectations for this figure to rise by 2034.
  • In 2023, the Neuropathic Ocular Pain (NOP) market consists of off-label therapies that provide only temporary and nonspecific relief, leading to an estimated market size of around USD 100 million across the 7MM.
  • In DelveInsight’s evaluation, Japan reported a total of 3,352 thousand cases of various eye disorders in 2023. Among these, severe Dry Eye Disease accounted for 36%, post-operative complications made up 13%, cataract surgery represented 29%, and other conditions, including infections, systemic diseases, and various ocular surface disorders, constituted 21%.
  • In 2023, the EU4 and the UK represented about 1,625 thousand cases of neuropathic ocular pain within the 7MM. Among the European nations, Italy reported the highest incidence, with approximately 535 thousand cases, while France followed with nearly 350 thousand cases.
  • According to DelveInsight’s projections for 2023, the EU4 and the UK represent 44% of the total cases of various eye disorders and surgeries across the 7MM, exceeding the US at 38% and Japan at 18%. These figures are anticipated to increase during the forecast period from 2024 to 2034, signaling a projected rise in the prevalence of these conditions.
  • The leading Neuropathic Ocular Pain Companies such as Novartis, OKYO Pharma, AbbVie Inc., Aciex Therapeutics, Novaliq, Oculeve and Allergan, Adverum Biotechnologies, MeiraGTx, Ocular Therapeutix, Aldeyra Therapeutics, IACTA Pharmaceuticals, Inc., Sun Pharmaceutical Ltd., SALVAT, Bausch & Lomb Incorporated, Kala Pharmaceuticals, Spectra Vision Care., Alcon Laboratories, AERIE PHARMACEUTICALS, INC., Optocred Pharmaceuticals, BRIM Biotechnology, Inc., and others
  • Promising Neuropathic Ocular Pain Therapies such as SAF312, OK-201, Lidocaine, Ketamine, Nerve stimulation, Gene Therapy, Gabapentin, Pregabalin, and others

 

Stay ahead in the Neuropathic Ocular Pain Therapeutics Market with DelveInsight’s Strategic Report @ Neuropathic Ocular Pain Market Outlook

 

Neuropathic Ocular Pain Epidemiology Segmentation in the 7MM

  • Total Prevalence of Neuropathic Ocular Pain
  • Prevalent Cases of Neuropathic Ocular Pain by severity
  • Gender-specific Prevalence of Neuropathic Ocular Pain
  • Diagnosed Cases of Episodic and Chronic Neuropathic Ocular Pain

 

Download the report to understand which factors are driving Neuropathic Ocular Pain epidemiology trends @ Neuropathic Ocular Pain Prevalence

 

Emerging Neuropathic Ocular Pain Drugs

  • OK-101: OKYO Pharma Limited

OK-101, developed by OKYA Pharma, represents a promising therapeutic approach for neuropathic corneal pain (NCP), a condition characterized by chronic pain in the cornea in response to stimuli that are normally non-painful. OK-101 is designed to target the underlying pathophysiological mechanisms of NCP, aiming to provide relief by addressing the specific nerve pain pathways involved in this disorder.

OK-101 is a selective ion channel modulator designed to address neuropathic corneal pain (NOP) by altering nerve signal transmission. This novel approach aims to provide more effective and targeted relief compared to existing treatments, which often offer only temporary relief for NOP. As clinical trials advance, OK-101 could significantly enhance management strategies for NOP, addressing a critical gap in effective, long-lasting pain relief.

 

Neuropathic Ocular Pain Market Outlook

Current treatments for neuropathic ocular pain (NOP) encompass both pharmacological and non-pharmacological approaches. Pharmacological options include topical anesthetics, such as lidocaine and tetracaine, which provide temporary relief by numbing the corneal surface. Additionally, nerve growth factor (NGF) inhibitors, like cenegermin, are used to promote corneal healing and alleviate pain by targeting underlying nerve damage. Antidepressants, such as amitriptyline, and anticonvulsants, like gabapentin, are sometimes prescribed off-label to manage chronic pain through their central pain-modulating effects

 

Get In-Depth Knowledge on Neuropathic Ocular Pain Market Trends and Forecasts with DelveInsight @ Neuropathic Ocular Pain Treatment Market

 

Neuropathic Ocular Pain Treatment Market

The pipeline for neuropathic ocular pain (NOP) treatments is notably limited. Few drug candidates are currently under development, reflecting the significant gap in addressing this condition. Despite ongoing research, the lack of innovative therapies means that effective, long-term solutions for NOP remain sparse, underscoring the urgent need for advancements in this area. However the pharmaceutical landscape is expected to evolve with ongoing clinical trials exploring novel treatments, including OK-101, and other drugs. Despite the absence of curative options, advancements in research and development, alongside a comprehensive approach is crucial for addressing the unmet needs in NOP treatment.

 

Neuropathic Ocular Pain Therapies and Companies

  • SAF312: Novartis
  • OK-201: OKYO Pharma
  • Lidocaine: Aciex Therapeutics
  • Ketamine: Novaliq
  • Nerve stimulation: Oculeve and Allergan
  • Gene Therapy: Adverum Biotechnologies and MeiraGTx
  • Gabapentin: Ocular Therapeutix
  • Pregabalin: Aldeyra Therapeutics

 

Unlock Strategic Insights with DelveInsight’s Comprehensive Neuropathic Ocular Pain Market Report @ Neuropathic Ocular Pain Market Drivers and Barriers

 

Scope of the Neuropathic Ocular Pain Market Report

  • Study Period: 2020-2034
  • Coverage: 7MM
  • Neuropathic Ocular Pain Companies: Novartis, OKYO Pharma, AbbVie Inc., Aciex Therapeutics, Novaliq, Oculeve and Allergan, Adverum Biotechnologies, MeiraGTx, Ocular Therapeutix, Aldeyra Therapeutics, IACTA Pharmaceuticals, Inc., Sun Pharmaceutical Ltd., SALVAT, Bausch & Lomb Incorporated, Kala Pharmaceuticals, Spectra Vision Care., Alcon Laboratories, AERIE PHARMACEUTICALS, INC., Optocred Pharmaceuticals, BRIM Biotechnology, Inc., and others
  • Neuropathic Ocular Pain Therapies: SAF312, OK-201, Lidocaine, Ketamine, Nerve stimulation, Gene Therapy, Gabapentin, Pregabalin, and others
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Neuropathic Ocular Pain Unmet Needs, KOL’s views, Analyst’s views, Neuropathic Ocular Pain Market Access and Reimbursement

 

Table of Contents

1. Neuropathic Ocular Pain Market Report Introduction

2. Executive Summary for Neuropathic Ocular Pain

3. SWOT analysis of Neuropathic Ocular Pain

4. Neuropathic Ocular Pain Patient Share (%) Overview at a Glance

5. Neuropathic Ocular Pain Market Overview at a Glance

6. Neuropathic Ocular Pain Disease Background and Overview

7. Neuropathic Ocular Pain Epidemiology and Patient Population

8. Country-Specific Patient Population of Neuropathic Ocular Pain

9. Neuropathic Ocular Pain Current Treatment and Medical Practices

10. Neuropathic Ocular Pain Unmet Needs

11. Neuropathic Ocular Pain Emerging Therapies

12. Neuropathic Ocular Pain Market Outlook

13. Country-Wise Neuropathic Ocular Pain Market Analysis (2020-2034)

14. Neuropathic Ocular Pain Market Access and Reimbursement of Therapies

15. Neuropathic Ocular Pain Market Drivers

16. Neuropathic Ocular Pain Market Barriers

17. Neuropathic Ocular Pain Appendix

18. Neuropathic Ocular Pain Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/case-study/respiratory-domain-conference-coverage

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Neuropathic Ocular Pain Market Size is expected to increase with a significant CAGR of 5.2% contributing to projected launch of emerging therapies by 2034, estimates DelveInsight